^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    QL-VIII-58

    i
    Other names: QL-VIII-58

    Associations

    News
    Trials
    Company:
    Dana-Farber Cancer Institute, Massachusetts General Hospital, Wellcome Sanger Institute
    Drug class:
    mTOR inhibitor, ATR inhibitor
    Related drugs:

    Associations

    News
    Trials